Boult Wade Tennant
/bulletin

Archives: Bulletins

March 11, 2026

Female inventorship in the UK

A UKIPO report reveals gradual growth in female inventors in UK patent filings from 1997–2024. Despite progress, women remain underrepresented across sectors and inventor teams.

March 9, 2026

Another referral in the wake of G1/24 – should the description be consulted when considering added subject matter?

Minutes from T 873/24 suggest a new referral to the Enlarged Board of Appeal on whether G 1/24—requiring consultation of the description when interpreting claims—also applies to added subject matter assessments.

March 6, 2026

International Women’s Day 2026 – helping women to thrive in IP through the Women and IP mentoring scheme

For International Women’s Day, Boult highlights our commitment to women in IP, supporting career growth through IP Inclusive and the new Women in IP mentoring scheme.

March 5, 2026

Generation vs innovation: an analysis of UK electricity generation and energy sector patent applications for 2025

The National Energy System Operator 2025 review shows renewables supplying 44% of UK electricity. Yet patent filings tell a different story, with gas leading innovation despite wind topping generation.

March 3, 2026

An update on late-filed divisional patent applications

Board of Appeal decision T 700/25 casts doubt on J 1/24’s limited path to filing divisionals after grant, reaffirming that applicants should file before the parent patent grants.

February 24, 2026

The EPO President’s comments on description amendments (case G1/25)

In G1/25, the EPO President confirms that amended claims must be matched by description amendments under Article 84 EPC, in both examination and opposition.

February 19, 2026

UK IPO fee rises for patents, trade marks and designs from 1 April 2026

UK IPO to raise patent, trade mark and design fees by 25% from 1 April 2026. Early renewals in some cases can secure current rates. Portfolio planning now essential.

February 17, 2026

An IP guide to Biosimilars

Overview of EMA-defined biosimilars, EU IP protections and limits including Bolar exemption, SPC manufacturing waiver, skinny labelling and loss of exclusivity strategies.

February 11, 2026

A farewell to Aerotel and a welcome to the “intermediate step” – the Supreme Court weighs in on Emotional Perception

The UK Supreme Court has reshaped software patent assessment, moving away from Aerotel toward greater EPO harmonisation and confirming that an ANN is a “program for a computer.”

February 10, 2026

What constitutes individual character and when online marketplaces can be used as prior art

Two recent invalidity decisions show the risks of relying on online marketplace listings as prior art and demonstrate how design freedom shapes assessments of novelty and individual character.